Lead Product(s): Ban2401
Therapeutic Area: Neurology
Highest Development Status: Phase III Product Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 03, 2020
The enrollment of patients with early Alzheimer's disease will be carried out at memory clinics at four Swedish university hospitals.